Sign In
Buy RHHBY
$54.64
-0.630 (-1.14%)
At Close: Jul 31, 2026
Roche announces positive phase II results for dual GLP-1/GIP receptor
01:12am, Tuesday, 27'th Jan 2026
Swiss pharmaceutical firm Roche said on Tuesday that a phase II clinical trial of CT-388, an investigational dual GLP-1/GIP receptor being developed to treat obesity, delivered positive results.
Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity
01:10am, Tuesday, 27'th Jan 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from CT388-103, a Phase II clinical trial of
Basel, 27 January 2026 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive topline results from CT388-103, a Phase II clinical trial of CT-388, an investigational dual GLP-1/GIP receptor ago
Gold headed to $6,000 - Veteran investor tells us why
01:13am, Thursday, 22'nd Jan 2026
David Roche from Quantum Strategy shared his outlook on markets amid geopolitical tensions, forecasting Japan's 10-year government bond yield to rise to 2.9% within a year as government debt increases
Roche's Genentech Expands Investment in North Carolina Facility to $2B
12:45pm, Wednesday, 21'st Jan 2026
Roche more than doubles Genentech's Holly Springs biomanufacturing investment to approximately $2B, boosting U.S. supply-chain resilience and metabolic drug production.
Roche's Genentech more than doubles investment in North Carolina facility to about $2 billion
11:19am, Tuesday, 20'th Jan 2026
Roche's Genentech said on Tuesday it will more than double its initial investment in a biomanufacturing facility in North Carolina to about $2 billion, as the companies look to further boost their $50
Genentech More than Doubles Investment in Holly Springs, North Carolina Manufacturing Facility
10:30am, Tuesday, 20'th Jan 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced an expansion of its initial investment in a new Holly Springs, North
Market Today: Chips, energy and housing lead -- TSM, MU, NVO in focus
05:35pm, Friday, 16'th Jan 2026
Guru Stock PicksRichard Pzena has made the following transactions:Add in MBUU by 2.48%Stock News Stocks end flat as chips rally: Taiwan Semiconductor (TSM) and
Market Today: TSMC beat, Goldman soars, Spotify hikes
05:35pm, Thursday, 15'th Jan 2026
Stock News Verizon issues credits after outage: Verizon (VZ) said it resolved a nationwide wireless outage and will offer a $20 account credit to affected custo
Analysts Set Roche Holding AG (OTCMKTS:RHHBY) Price Target at $57.00
04:52am, Wednesday, 14'th Jan 2026
Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the nine research firms that are currently covering the company, Marke
BGI, Roche roll out diagnostic tests for Alzheimer's in China
10:23pm, Tuesday, 13'th Jan 2026
BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort to expand access to easier-to-use diagnosis and monitoring choices for patie
MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche
07:00pm, Thursday, 08'th Jan 2026
/PRNewswire/ -- MediLink Therapeutics ("MediLink") today announced that it has entered into a new collaboration and exclusive licensing agreement with Roche
First Look: Apple-JPM card deal, Ford L3, defense clampdown
07:38am, Thursday, 08'th Jan 2026
Stock News Trump targets Wall Street homebuying: President Trump proposed banning large institutional investors from purchasing single-family homes, sending sha
Market Today: Trump Housing Ban, Apple Card Shift, ISM Jump
05:34pm, Wednesday, 07'th Jan 2026
Guru Stock PicksRon Baron has made the following transactions:Add in CHH by 39.44%Manning and Napier Group, LLC has made the following transactions:Reduce in RMOP
First Look: Nvidia, Ford, Novo Nordisk and Hyundai in Focus
07:39am, Wednesday, 07'th Jan 2026
Stock News WBD sticks with Netflix deal: Warner Bros. Discovery (WBD) again rejected Paramount's (PARA) hostile bid, reaffirming its $72B agreement to sell its
